Insights
Search Results
Client Highlights
2.23.26
Firm Advises Arcellx on $7.8 Billion Acquisition by Gilead
On February 23, 2026, Gilead Sciences announced that it has entered into a definitive agreement to acquire Arcellx, a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction.
Client Highlights
5.21.25
Wilson Sonsini Advises Yext on $200 Million Debt Facility with BlackRock
On May 21, 2025, Yext, Inc., a leading digital presence platform for multi-location brands, announced that it has closed a $200 million senior secured term loan facility with funds and accounts managed by BlackRock, providing the company with enhanced flexibility to support its growth initiatives and strategic objectives. Wilson Sonsini Goodrich & Rosati advised Yext on the transaction. Proceeds of the facility will be used to support growth initiatives and pursue strategic acquisitions.
Client Highlights
2.12.25
Wilson Sonsini Advises Yext on Acquisition of Places Scout
On February 10, 2025, Yext, Inc., a leading digital presence platform for multi-location brands, announced its acquisition of Places Scout, an industry-leading local SEO and location intelligence platform. Places Scout delivers real-time, location-based insights to assess performance, track competitors, and optimize visibility across every major search channel. The acquisition strengthens Yext's ability to provide best-in-class competitive intelligence, benchmarking, and AI-powered insights. Wilson Sonsini Goodrich & Rosati advised Yext on the transaction.
Client Highlights
1.28.25
Wilson Sonsini Advises Ascentage Pharma on U.S. Initial Public Offering and Nasdaq Listing
On January 28, 2025, Ascentage Pharma Group International announced the closing of its U.S. initial public offering of 7,325,000 American depositary shares (ADSs) at a public offering price of $17.25 per ADS, before underwriting discounts and commissions. Each ADS represents four ordinary shares of Ascentage Pharma. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Ascentage Pharma, were approximately $126.4 million. In addition, Ascentage Pharma has granted the underwriters a 30-day option to purchase up to an additional 1,098,750 ADSs at the initial public offering price, less underwriting discounts and commissions. The ADSs began trading on the Nasdaq Global Market on January 24, 2025.
Client Highlights
8.02.24
Wilson Sonsini Advises Aurora on $483 Million Upsized Public Offering
On August 2, 2024, Aurora Innovation, Inc., a self-driving vehicle technology company, announced the closing of its underwritten upsized public offering for total gross proceeds of approximately $483 million, before deducting underwriting discounts and commissions and other offering expenses. In the public offering, Aurora sold 134,166,667 shares of its Class A common stock at $3.60 per share, which includes the full exercise by the underwriters of their option to purchase up to 17,500,000 additional shares.
Client Highlights
6.10.24
Wilson Sonsini Advises Yext on $125 Million Acquisition of Hearsay Systems
On June 10, 2024, Yext, Inc., the leading digital presence platform for multi-location brands, announced that it has entered into a definitive agreement to acquire Hearsay Systems, a global leader in digital client engagement for financial services, for $125 million and up to an additional $95 million if certain performance targets are achieved. Wilson Sonsini Goodrich & Rosati advised Yext on the transaction.
Client Highlights
10.06.23
Firm Advises Spark I Acquisition Corporation on $100 Million IPO
On October 5, 2023, Spark I Acquisition Corporation (the “Company”), a special purpose acquisition company, announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Global Market and trade under the ticker symbol "SPKLU" beginning on October 6, 2023. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols "SPKL" and "SPKLW," respectively. Wilson Sonsini Goodrich & Rosati is advising the Company on the transaction.
Client Highlights
7.31.23
Wilson Sonsini Advises Aurora on $820 Million Upsized Public Offering and Private Placement of Class A Common Stock
On July 24, 2023, Aurora Innovation, Inc. announced the closing of its previously announced underwritten public offering and concurrent private placement, with participation from certain existing institutional and strategic investors, entities affiliated with two of Aurora’s directors, and new institutional investors, for total gross proceeds of approximately $820 million.
Client Highlights
9.19.22
Wilson Sonsini Represents Amprius Technologies in SPAC Transaction
On September 14, 2022, Amprius Technologies, Inc., a lithium-ion batteries manufacturer, announced the completion of its business combination with Kensington Capital Acquisition Corp IV, a special purpose acquisition company. The company has begun trading on the New York Stock Exchange under the ticker symbol “AMPX.” The transaction will provide Amprius with approximately $87 million of gross proceeds, which will be used to support the company through the construction of its gigawatt hour-scale manufacturing facility.
Client Highlights
7.16.21
Wilson Sonsini Represents Aurora in Merger with Reinvent Technology Partners Y
On July 15, 2021, Aurora, the self-driving technology company, has entered into a definitive business combination agreement with Reinvent Technology Partners Y (Reinvent), a special purpose acquisition company (SPAC). Upon closing of the proposed transaction, the combined company will be named Aurora Innovation, Inc. and be publicly traded, with its common stock expected to be listed on Nasdaq with the ticker symbol "AUR." Wilson Sonsini Goodrich & Rosati is representing Aurora in the transaction.
Client Highlights
7.02.21
Firm Advises Underwriters on MongoDB’s Upsized Public Offering
On June 29, 2021, MongoDB, Inc., the leading, modern general purpose database platform, announced the pricing of an underwritten public offering of 2,500,000 shares of its Class A common stock at a price to the public of $365.00 per share. MongoDB estimates that the net proceeds from the sale of the shares will be approximately $889.0 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by MongoDB. Wilson Sonsini Goodrich & Rosati represented the underwriters in the offering, which closed on Friday, July 2, 2021.
Morgan Stanley and Goldman Sachs & Co. LLC acted as joint book-running managers for the offering. Drexel Hamilton, Guzman & Company, Siebert Williams Shank, and Tigress Financial Partners acted as co-managers for the offering.
The Wilson Sonsini team advising the underwriters in the transaction includes Mike Labriola, Megan Baier, Mark Bass, Hyo Min Kim, and Norman Zhang.
For more information, please see MongoDB’s press release.
Morgan Stanley and Goldman Sachs & Co. LLC acted as joint book-running managers for the offering. Drexel Hamilton, Guzman & Company, Siebert Williams Shank, and Tigress Financial Partners acted as co-managers for the offering.
The Wilson Sonsini team advising the underwriters in the transaction includes Mike Labriola, Megan Baier, Mark Bass, Hyo Min Kim, and Norman Zhang.
For more information, please see MongoDB’s press release.